0001577526-26-000024
SEC filingC3.ai, Inc. reported a net loss of $133.4 million for Q3 2026, with total revenue of $53.3 million. The company generated a gross profit of $9.2 million, representing a gross margin of 17.3%. Operating expenses totaled $149.6 million, resulting in an operating loss of $140.4 million. The company's cash position decreased by $75.5 million during the quarter, ending with total cash, cash equivalents and restricted cash of $176.9 million. Balance sheet strength is maintained with total assets of $895.8 million and stockholders' equity of $719.5 million. The company continues to invest heavily in research and development ($58.8 million) and sales and marketing ($67.2 million) while generating significant stock-based compensation expense of $209.5 million.
C3.ai, Inc. reported financial results for Q3 2026 ending January 31, 2026. The company generated total revenue of $53.3 million with a gross profit of $9.2 million, representing a gross margin of 17.3%. Operating expenses totaled $149.6 million, consisting of $67.2 million in sales and marketing, $58.8 million in research and development, and $23.6 million in general and administrative expenses. This resulted in an operating loss of $140.4 million. After accounting for $6.7 million in interest income and $519,000 in other income, net, and a $174,000 provision for income taxes, the company reported a net loss of $133.4 million. Basic and diluted net loss per share was $1.00, based on 142.0 million weighted-average shares.
The filing does not provide segment breakdown or geographic mix data. Total revenue of $53.3 million represents the consolidated figure for the quarter. No specific revenue drivers or product/service breakdowns are disclosed in the provided data. The company's revenue generation appears to be from its core operations, but without segment disclosure, detailed analysis of revenue composition is not possible based on the available information.
The company reported a gross margin of 17.3% for Q3 2026, calculated from $9.2 million gross profit on $53.3 million revenue. Operating margin was negative 263.4%, reflecting the significant operating loss relative to revenue. The cost structure shows high operating expenses relative to revenue, with sales and marketing representing 126.1% of revenue, research and development representing 110.3% of revenue, and general and administrative representing 44.3% of revenue. Stock-based compensation expense of $209.5 million was a significant non-cash expense impacting profitability metrics.
Net cash used in operating activities was $135.8 million, primarily driven by the net loss of $133.4 million, adjusted for non-cash items including $209.5 million in stock-based compensation. Investing activities provided $51.2 million in cash, mainly from $496.1 million in maturities and sales of marketable securities offset by $443.4 million in purchases. Financing activities provided $9.1 million from stock issuances. Total cash, cash equivalents and restricted cash decreased by $75.5 million to $176.9 million. The balance sheet shows total assets of $895.8 million, including $782.7 million in current assets with $88.8 million in cash and cash equivalents and $533.1 million in marketable securities. Total liabilities were $176.3 million, resulting in stockholders' equity of $719.5 million.
The filing does not contain management guidance, strategic priorities, or specific risk factor disclosures in the provided content. No forward-looking statements or outlook information is included in the extracted financial data. Investors should refer to the complete 10-Q filing for any management discussion and analysis, risk factors, or forward-looking statements that may provide insight into the company's future expectations and strategic direction.